LJI Wealth Management LLC Sells 530 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

LJI Wealth Management LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,855 shares of the exchange traded fund’s stock after selling 530 shares during the period. LJI Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,962,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $44,000. Waldron Private Wealth LLC bought a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $54,000. Finally, Resources Management Corp CT ADV increased its stake in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after acquiring an additional 138 shares during the period.

SPDR S&P Biotech ETF Stock Down 5.3 %

Shares of XBI stock traded down $5.13 during trading hours on Friday, reaching $91.83. The company’s stock had a trading volume of 30,310,242 shares, compared to its average volume of 9,463,345. The firm’s 50 day simple moving average is $98.95 and its 200-day simple moving average is $96.03. The company has a market capitalization of $7.00 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $69.32 and a fifty-two week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.